Padmaseetha Technologies

What Padmaseetha Technologies does

Padmaseetha Technologies Private Limited is an India-based medical device company founded in 2014 in Mylapore, Chennai, that develops portable peritoneal dialysis (PD) solutions for end-stage renal disease patients. Its flagship product, OmniPD, is described as the world's first portable PD cycler and is paired with a cloud-based patient management system, an intuitive smartphone app for patient self-management, and SMS/email alerts that keep patients connected with their doctors for preventive care. The company has extended this core technology into two adjacent offerings: SmartPD, a cloud-connected smart PD solution, and VetPD, a portable dialysis device for veterinary applications.

The company operates a direct-to-consumer go-to-market via its website and phone channel, targeting renal patients in India — particularly those in rural areas who currently travel many hours to reach dialysis centers. Its revenue model combines hardware sales of the OmniPD device with ongoing renal care services and patient monitoring delivered through the cloud platform. Pricing is not publicly disclosed; prospective buyers are directed to contact the company directly. Geographic operations are India-only with no disclosed distribution partners or institutional buyers.

Padmaseetha has been funded exclusively through non-dilutive grants from Indian government bodies — including BIRAC (BIG and SBIRI grants), IIT Madras Alumni, MSME, DST/TDB, and IIGP — and international recognition via the IndoUSSTF Award. In 2024, the company joined MedTech Innovator, the largest medical device accelerator, suggesting intent to access US market pathways. The leadership team consists of Founder & CEO Gowrishankar and Tech Lead Santhosh, with reported headcount in the 1-10 range. No equity funding rounds, revenue figures, regulatory clearances, patents, or enterprise customers are disclosed in available source material.

Name

Padmaseetha Technologies

Legal name

Padmaseetha Technologies Private Limited

Website

https://padmaseetha.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

Padmaseetha Technologies is an India-based medical device company that develops OmniPD, a portable peritoneal dialysis cycler with cloud-based patient management and smartphone app integration, serving end-stage renal disease patients in rural India.

Ownership category

akta.pro rank

Product category

Peritoneal Dialysis Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro industry

PRIMARYHLAHAKAB

Peritoneal Dialysis (PD) Systems & Supplies

Healthcare & Life Sciences/Medical Devices & Diagnostics/Renal & Dialysis Devices

SECONDARYHLAHAKAG

Home Dialysis Equipment & Remote Monitoring

Healthcare & Life Sciences/Medical Devices & Diagnostics/Renal & Dialysis Devices

SECONDARYHLAKAHAK

Home Dialysis Programs (Home HD/PD Training & Support)

Healthcare & Life Sciences/Specialist Medical Practice/Nephrology

Keywords

• Peritoneal dialysis devices
• Portable medical devices
• Renal healthcare solutions
• Home dialysis equipment
• Dialysis patient monitoring

Headquarters

HQ city

Mylapore

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. OmniPD Device Sales: Sale of the OmniPD portable peritoneal dialysis cycler hardware to renal patients and healthcare providers.
2. Renal Care Services: Specialized renal care services offered to renal patients, catered to fit their individual needs. Includes ongoing patient monitoring through the cloud-based system.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Padmaseetha Technologies designs, develops, and sells portable peritoneal dialysis (PD) medical devices, with its flagship product OmniPD being the world's first portable PD cycler that enables patients to perform dialysis anytime and anywhere. The company's offerings center on a portfolio of portable dialysis hardware (OmniPD, VetPD, SmartPD) bundled with a cloud-based patient management system, a companion smartphone app, and ongoing renal care services for patients with end-stage renal disease.

Product overview

Padmaseetha Technologies offers a portfolio of portable peritoneal dialysis solutions centered around OmniPD as the core product. The company provides VetPD, OmniPD, and SmartPD as distinct product offerings. OmniPD is described as the world's first portable PD cycler, allowing patients to perform dialysis anytime, anywhere through an intuitive smartphone app. A cloud-based patient management system enables continuous doctor-patient connectivity, with SMS and email alerts for preventive care. The portfolio represents mobile medical devices designed for renal healthcare accessibility.

Differentiator

Problem solved

Functional benefit

Brands

• OmniPD: World's first portable PD cycler allowing peritoneal dialysis to be carried out anytime, anywhere.
• SmartPD
• VetPD

Products and services

• OmniPD Portable PD Cycler World's first portable peritoneal dialysis (PD) cycler that allows renal patients to carry out dialysis anytime and anywhere through an intuitive smartphone app, eliminating the need to break from work or travel long distances to a dialysis centre. Designed for end-stage renal disease patients, including those in remote and rural areas.
• VetPD Portable peritoneal dialysis device adapted for veterinary use, extending Padmaseetha's portable dialysis technology to animal patients.
• SmartPD Smart peritoneal dialysis solution that connects patients with their doctors through a cloud-based patient management system, enabling ongoing remote monitoring of dialysis data and preventive-care alerts via SMS and email.
• Renal Care Services Specialized renal care services tailored to the individual needs of renal patients, including ongoing remote monitoring of dialysis data through the cloud-based patient management system and preventive-care alerts. Intended for end-stage renal disease patients using the company's portable dialysis devices.

Quantifiable outcome

• More than 90% of patients give up hope and die as their earnings are insufficient to manage treatment and families - OmniPD aims to address this by making dialysis more affordable and accessible.

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Baxter International: Global market leader in peritoneal dialysis with the Amia, Homechoice, and Kaguya cyclers, plus PD solutions. Comparable because Baxter defines the existing PD cycler category that Padmaseetha's OmniPD directly targets with a portable form factor.
• Medtronic: Large diversified medical device company active across connected health, monitoring, and chronic disease management. Comparable as a potential strategic acquirer or partner for a small renal-care innovator, and a benchmark for the connected-device architecture OmniPD is building.
• DaVita: Largest US dialysis services provider operating thousands of centers and increasingly building home dialysis programs. Comparable because DaVita is both a potential channel partner and a competitive threat as it expands into home/PD modalities.
• NxStage Medical (Fresenius): Now part of Fresenius, NxStage pioneered portable home hemodialysis with the System One. Comparable because NxStage established the portable-home-dialysis category that OmniPD is extending into peritoneal dialysis.
• Fresenius Medical Care: World's largest dialysis services and products company, with PD cyclers (sleep•safe), dialyzers, and clinic operations. Comparable because Fresenius operates across the same renal-care value chain and is the dominant global competitor in both HD and PD.

Direct peers

• Outset Medical: Maker of Tablo, a connected, in-clinic and home hemodialysis system with cloud data and a simplified user interface. Comparable because Tablo competes on portability, connectivity, and ease-of-use in the home dialysis market where OmniPD also plays.

Emerging players

• Cricket Health: US-based kidney-care company combining technology-enabled care management with home dialysis. Comparable as a peer tackling the same chronic kidney disease patient journey through connected, home-first renal care rather than center-based dialysis.
• Quanta Dialysis Technologies: UK-based developer of the small, portable hemodialysis system SC+. Comparable as a competitor pursuing a compact, easy-to-use dialysis device for use outside traditional centers — a similar design philosophy to OmniPD's portable PD cycler.
• AWAK Technologies: Singapore-based medtech developing a wearable/portable PD device (AWAK PD). Highly comparable because AWAK is also pursuing miniaturized, on-the-go peritoneal dialysis — directly overlapping with OmniPD's portability thesis.

Regional players

• Asahi Kasei Medical: Japanese manufacturer of dialysis products including dialyzers and PD systems. Comparable as an Asia-based dialysis device maker serving similar patient demographics to Padmaseetha's Indian rural focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Padmaseetha Technologies